
Therapeutic Goods (Medical Devices—Excluded Purposes) Specification 2020
made under section 41BEA of the
Therapeutic Goods Act 1989
Compilation No. 2
Compilation date: 28 October 2022
Includes amendments up to: F2022L01403
About this compilation
This compilation
This is a compilation of the Therapeutic Goods (Medical Devices—Excluded Purposes) Specification 2020 that shows the text of the law as amended and in force on 28 October 2022 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
1 Name................................................................................................................................................... 1
3 Authority............................................................................................................................................. 1
4 Definitions........................................................................................................................................... 1
4A Excluded purposes—Class 1 IVD medical devices.......................................................................... 1
5 Excluded purposes—Class 2 IVD medical devices............................................................................. 2
6 Excluded purposes—Class 3 and 4 IVD medical devices................................................................... 2
Schedule 1—Excluded purposes....................................................... 3
Part 1A—Class 1 IVD medical devices.............................................................................. 3
Part 1—Class 2 IVD medical devices................................................................................. 3
Part 2—Class 3 and 4 IVD medical devices....................................................................... 4
Endnotes............................................................................................................................... 5
Endnote 1—About the endnotes..................................................................................... 5
Endnote 2—Abbreviation key........................................................................................ 6
Endnote 3—Legislation history....................................................................................... 7
Endnote 4—Amendment history.................................................................................... 8
1 Name
This instrument is the Therapeutic Goods (Medical Devices—Excluded Purposes) Specification 2020.
3 Authority
This instrument is made under section 41BEA of the Therapeutic Goods Act 1989.
4 Definitions
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) medical device; and
(b) State.
In this instrument:
Act means the Therapeutic Goods Act 1989.
Class 1 IVD medical device has the same meaning as in the Regulations.
Class 2 IVD medical device has the same meaning as in the Regulations.
Class 3 IVD medical device has the same meaning as in the Regulations.
Class 4 IVD medical device has the same meaning as in the Regulations.
government health screening program means a health screening program that is conducted, approved or funded by the Commonwealth or a State.
Note: State is defined in subsection 3(1) of the Act as including the Australian Capital Territory and the Northern Territory.
IVD medical device for self-testing has the same meaning as in the Regulations.
Regulations means the Therapeutic Goods (Medical Devices) Regulations 2002.
SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2, means the virus that causes coronavirus disease (COVID-19).
Note: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the name given by the International Committee on Taxonomy of Viruses to the virus that causes coronavirus disease (COVID-19).
serious disease has the same meaning as in the Regulations.
4A Excluded purposes—Class 1 IVD medical devices
(1) This section applies in relation to medical devices that are:
(a) IVD medical devices for self-testing; and
(b) Class 1 IVD medical devices; and
(c) not intended to be used exclusively for testing to monitor a disease or condition that has been diagnosed by a suitably qualified health professional; and
(d) not intended exclusively for export; and
(e) not intended to be used exclusively for testing as part of a government health screening program.
(2) The purposes mentioned in Part 1A of Schedule 1 are specified for the purposes of paragraph 41FD(ia) and subsection 41FF(1A) of the Act.
5 Excluded purposes—Class 2 IVD medical devices
(1) This section applies in relation to medical devices that are:
(a) IVD medical devices for self-testing; and
(b) Class 2 IVD medical devices; and
(c) not intended exclusively for export; and
(d) not intended to be used exclusively for testing as part of a government health screening program.
(2) The purposes mentioned in Part 1 of Schedule 1 are specified for the purposes of paragraph 41FD(ia) and subsection 41FF(1A) of the Act.
6 Excluded purposes—Class 3 and 4 IVD medical devices
(1) This section applies in relation to medical devices that are:
(a) IVD medical devices for self-testing; and
(b) Class 3 IVD medical devices or Class 4 IVD medical devices; and
(c) not intended to be used exclusively for testing to monitor a disease or condition that has been diagnosed by a suitably qualified health professional; and
(d) not intended exclusively for export; and
(e) not intended to be used exclusively for testing as part of a government health screening program.
(2) The purposes mentioned in Part 2 of Schedule 1 are specified for the purposes of paragraph 41FD(ia) and subsection 41FF(1A) of the Act.
Schedule 1—Excluded purposes
Part 1A—Class 1 IVD medical devices
Note: See section 4A.
Part 1—Class 2 IVD medical devices
Note: See section 5.
Excluded purposes |
Column 1 | Column 2 |
Item | Purposes |
1 | testing for faecal occult blood |
Part 2—Class 3 and 4 IVD medical devices
Note: See section 6.
Excluded purposes |
Column 1 | Column 2 |
Item | Purposes |
1 | testing specimens from the human body, other than to: (a) test for the presence of, or exposure to any of the following pathogenic organisms or transmissible agents: (i) chlamydia trachomatis; (ii) hepatitis B virus; (iii) hepatitis C virus; (iv) herpes simplex virus type 1 and 2; (v) human immunodeficiency virus type 1 and type 2; (vi) seasonal influenza virus; (vii) neisseria gonorrhoea; (viii) treponema pallidum (syphilis); or (b) diagnose, aid in diagnosis of, indicate the presence of, or test for the presence of markers that are precursors to, any of the following diseases or conditions, other than by genetic testing: (i) diabetes; (ii) kidney disease; (iii) cardiovascular disease; or (c) test for the presence of SARS-CoV-2 antigens or SARS-CoV-2 nucleic acid |
Endnotes
Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.
If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.
Endnote 2—Abbreviation key
ad = added or inserted | orig = original |
am = amended | par = paragraph(s)/subparagraph(s) |
amdt = amendment | /sub‑subparagraph(s) |
c = clause(s) | pres = present |
C[x] = Compilation No. x | prev = previous |
Ch = Chapter(s) | (prev…) = previously |
def = definition(s) | Pt = Part(s) |
Dict = Dictionary | r = regulation(s)/rule(s) |
disallowed = disallowed by Parliament | reloc = relocated |
Div = Division(s) | renum = renumbered |
exp = expires/expired or ceases/ceased to have | rep = repealed |
effect | rs = repealed and substituted |
F = Federal Register of Legislation | s = section(s)/subsection(s) |
gaz = gazette | Sch = Schedule(s) |
LA = Legislation Act 2003 | Sdiv = Subdivision(s) |
LIA = Legislative Instruments Act 2003 | SLI = Select Legislative Instrument |
(md not incorp) = misdescribed amendment | SR = Statutory Rules |
cannot be given effect | Sub‑Ch = Sub‑Chapter(s) |
mod = modified/modification | SubPt = Subpart(s) |
No. = Number(s) | underlining = whole or part not |
o = order(s) | commenced or to be commenced |
Ord = Ordinance | |
Endnote 3—Legislation history
Name | Registration | Commencement | Application, saving and transitional provisions |
Therapeutic Goods (Medical Devices—Excluded Purposes) Specification 2020 | 9 Sep 2020 (F2020L01150) | 1 Oct 2020 | — |
Therapeutic Goods (Medical Devices—Excluded Purposes) Amendment (COVID-19 Rapid Antigen IVD Medical Devices for Self-Testing) Specification 2021 | 29 Sep 2021 (F2021L01347) | 1 Oct 2021 | — |
Therapeutic Goods (Medical Devices—Excluded Purposes) Amendment (COVID-19 Self-Testing) Specification 2022 | 27 Oct 2022 (F2022L01403) | 28 Oct 2022 | — |
Endnote 4—Amendment history
Provision affected | How affected |
s 2........................................ | rep LA s 48D |
s 4........................................ | am F2021L01347 |
s 4A..................................... s 7........................................ | ad F2021L01347 rep LA s 48C |
Schedule 1........................... Schedule 2........................... | am F2021L01347; F2022L01403 rep LA s 48C |